Tokyo, June 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058068) titled 'A Multicenter Retrospective Observational Study on the Efficacy and Safety of Peptide Receptor Radionuclide Therapy (PRRT) Retreatment (R-PRRT) Using 177Lu-DOTATATE for Neuroendocrine Neoplasms (NEN)' on June 3.
Study Type:
Observational
Primary Sponsor:
Institute - National Cancer Center Hospital
Condition:
Condition - Neuroendocrine Neoplasms
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to evaluate the efficacy and safety of retreatment with 177Lu-DOTATATE peptide receptor radionuclide therapy for neuroendocrine neoplasms, using data obtai...